VEGFA and Stroke: Interestingly, the most commonly prescribed drug for acute management of stroke, rtPA, generates adverse side effects including increased BBB permeability (Suzuki et al., 2016), in great part via activation of VEGF signaling and increased transcytosis (Benchenane et al., 2005; Turner and Vink, 2012).